The National Institute of Allergy and Infectious Diseases is offering a grant to support research aiming to bridge knowledge gaps for the development of bacteriophages in combatting drug-resistant bacterial infections. This opportunity focuses on basic and translational research to advance the understanding and regulation of bacteriophages for therapeutic applications. Applications are accepted until March 18, 2020.
Opportunity ID: 321497
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-19-065 |
| Funding Opportunity Title: | Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 10, 2019 |
| Last Updated Date: | Oct 10, 2019 |
| Original Closing Date for Applications: | Mar 18, 2020 |
| Current Closing Date for Applications: | Mar 18, 2020 |
| Archive Date: | Apr 23, 2020 |
| Estimated Total Program Funding: | $2,500,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Small businesses For profit organizations other than small businesses Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Private institutions of higher education County governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This initiative will support basic and translational research to address knowledge gaps that hinder the development and regulation of bacteriophage used to prevent and treat drug-resistant bacterial infections. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-065.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259750 | Feb 18, 2020 | Mar 18, 2020 | View | |
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00255767 | Feb 18, 2020 | May 24, 2020 | View |
Package 1
Mandatory forms
321497 RR_SF424_2_0-2.0.pdf
321497 PHS398_CoverPageSupplement_5_0-5.0.pdf
321497 RR_OtherProjectInfo_1_4-1.4.pdf
321497 PerformanceSite_2_0-2.0.pdf
321497 RR_KeyPersonExpanded_2_0-2.0.pdf
321497 PHS398_ResearchPlan_4_0-4.0.pdf
321497 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
321497 RR_Budget_1_4-1.4.pdf
321497 RR_SubawardBudget30_1_4-1.4.pdf
321497 PHS398_ModularBudget_1_2-1.2.pdf
321497 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
321497 RR_SF424_2_0-2.0.pdf
321497 PHS398_CoverPageSupplement_4_0-4.0.pdf
321497 RR_OtherProjectInfo_1_4-1.4.pdf
321497 PerformanceSite_2_0-2.0.pdf
321497 RR_KeyPersonExpanded_2_0-2.0.pdf
321497 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
321497 RR_Budget_1_4-1.4.pdf
321497 RR_SubawardBudget30_1_4-1.4.pdf
321497 PHS398_ModularBudget_1_2-1.2.pdf
321497 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
